Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sirius XM Holdings Inc (SIRI) vs GeneDx Holdings Corp (WGS) Price & Performance

Sirius XM Holdings IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Sirius XM Holdings Inc vs GeneDx Holdings Corp — how do they compare? Sirius XM Holdings Inc trades at $30.18 (market cap $10.30B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Sirius XM Holdings Inc is far larger — about 5.7× GeneDx Holdings Corp's market cap, and Sirius XM Holdings Inc pays a 3.53% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

SIRIWGS
Market Cap
$10.30B$1.80B
Sector
MediaTechnology
52-Week High
$31.22$167.51
52-Week Low
$19.92$34.51
Enterprise Value
$19.97B$1.80B
Dividend Yield
3.53%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sirius XM Holdings Inc

Sirius XM (SIRI) trades at $30.29, down 0.98% on the day, with a bullish technical signal from moving averages and recent earnings beats. The stock shows solid fundamentals with a P/E of 12.97, net income margin of 9.86%, and a recent dividend payment. Revenue stabilized around $8.6B in 2025 after a dip in 2024, while debt-to-asset ratio improved to 35.63%.

Outlook is positive with analyst consensus at Buy (58% of ratings) and a $30.71 price target, though risks include competitive pressures and reliance on subscription growth. The YouTube ad partnership and inclusion in the S&P MidCap 400 provide catalysts, but investors should monitor Q2 2026 earnings due July 30 for confirmation of trends.

GeneDx Holdings Corp

GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.

Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.

Returns comparison

Trailing returns across standard periods

About Sirius XM Holdings Inc

SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.

Read more on SIRI

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS